Optimal time between completion of preoperative chemotherapy and surgery for locally advanced pancreatic cancer

Multimodal treatment with preoperative chemotherapy is increasingly used for locally advanced pancreatic cancer (LAPC) to enable surgical resection. However, the optimal time between the last cycle of preoperative chemotherapy and surgery remains unclear. This study aimed to evaluate the association...

Full description

Saved in:
Bibliographic Details
Main Authors: Cathomas, Marionna (Author) , Kahlert, Christoph (Author) , Hank, Thomas (Author) , Rompen, Ingmar F. (Author) , Kryschi, Maximilian C. (Author) , Hinz, Ulf (Author) , Hackert, Thilo (Author) , Saeedi, Mohammed al (Author) , Büchler, Markus W. (Author) , Loos, Martin (Author)
Format: Article (Journal)
Language:English
Published: 03 March 2026
In: Annals of surgical oncology
Year: 2026, Volume: 33, Issue: 6, Pages: 5060-5067
ISSN:1534-4681
DOI:10.1245/s10434-026-19264-2
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1245/s10434-026-19264-2
Get full text
Author Notes:Marionna Cathomas, Christoph Kahlert, Thomas Hank, Ingmar Rompen, Maximilian Kryschi, Ulf Hinz, Thilo Hackert, Mohammed Al-Saeedi, Markus W. Büchler, Martin Loos
Description
Summary:Multimodal treatment with preoperative chemotherapy is increasingly used for locally advanced pancreatic cancer (LAPC) to enable surgical resection. However, the optimal time between the last cycle of preoperative chemotherapy and surgery remains unclear. This study aimed to evaluate the association between timing of surgery after preoperative chemotherapy and overall survival of patients with LAPC.
Item Description:Gesehen am 22.05.2026
Physical Description:Online Resource
ISSN:1534-4681
DOI:10.1245/s10434-026-19264-2